Treatment of Acne Scars With Erbium:Yttrium Aluminum Garnet (Er:YAG) Laser Examined Under OCT



Status:Withdrawn
Conditions:Acne, Acne, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:18 - 90
Updated:7/28/2018
Start Date:August 2018
End Date:December 2018

Use our guide to learn which trials are right for you!

Treatment of Atrophic Facial Acne Scars With Er:YAG Laser Examined Under Optical Coherence Tomography

This study is examining the effects of the 2940 nm Er:YAG on atrophic facial acne scars under
optical coherence tomography in terms of blood flow, vessel shape, skin roughness, collagen
content, and epidermal thickness.


Inclusion Criteria:

1. Patients should be 18-90 years of age

2. Patients should have Fitzpatrick skin types of I-III

3. Patients should have at least mild acne

Exclusion Criteria:

1. The patient should not be receiving any additional systemic, topical, or intralesional
treatment of the scars during the study

2. Pregnant or lactating females

3. Fitzpatrick skin type of IV-VI

4. A history of keloids or hypertrophic scars

5. Scleroderma

6. Photosensitivity

7. Botulinum toxin injection, facial laser resurfacing, chemical peels, fillers, or usage
of oral retinoid within the last 6 months

8. Subjects with a known history of herpes simplex
We found this trial at
1
site
Miami, Florida 33136
Principal Investigator: Keyvan Nouri, MD
Phone: 305-243-3380
?
mi
from
Miami, FL
Click here to add this to my saved trials